Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Public Health

Sec. Public Health Education and Promotion

Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study

Provisionally accepted
Miroslav  SvetlakMiroslav Svetlak1,2Michal  StandaraMichal Standara2*Tatiana  MalatincováTatiana Malatincová1Michal  StaníkMichal Staník2David  MiklánekDavid Miklánek2Kateřina  HejcmanováKateřina Hejcmanová1Miloš  PacalMiloš Pacal2Roman  HrabecRoman Hrabec2Ondřej  NgoOndřej Ngo1Karel  HejdukKarel Hejduk1Jan  KřístekJan Křístek2Michal  UherMichal Uher2Ondřej  MájekOndřej Májek1Alexandr  PoprachAlexandr Poprach2
  • 1Faculty of Medicine, Masaryk University, Brno, Czechia
  • 2Masarykuv onkologicky ustav, Brno, Czechia

The final, formatted version of the article will be published soon.

Background Prostate cancer remains a significant public health challenge, an early detection with prostate-specific antigen (PSA) testing and biparametric MRI (bpMRI) can improve outcomes. However, participation hinges on motivational, psychological, and logistical factors. This study examines the motivational profile of men in the ProstaPilot study to guide strategies to increase uptake of state-of-the-art prostate cancer screening programs. Methods The ProstaPilot study enrolled 423 men who underwent both PSA testing and bpMRI of the prostate. Positive results (PSA ≥ 3 µg/L or PI-RADS 4-5 lesions) were referred for further urological examination and biopsy. Using an exploratory correlational design, 360 participants completed a detailed questionnaire. Motivational factors were extracted via Principal Component Analysis with Oblimin rotation (PCA). Perceptions of prostate cancer risk, severity, and prevention were rated on 1–10 scales (10 = most positive). Results PCA identified four motivational factors explaining 55.6% of variance: (1) concerns about screening (e.g., unnecessary surgery, loss of control); (2) perceived benefits of early detection; (3) social motivation (e.g., contributing to research, role modeling); and (4) barriers (e.g., logistics, embarrassment). Over half (51.1%) had not considered screening before ProstaPilot; others decided over varying timeframes. Participants showed high awareness of prostate cancer and valued early detection, rating screening effectiveness 9.55 ± 0.98 and trust in healthcare professionals 9.6 ± 1.0. Social/familial influences were moderate. Satisfaction was high: likelihood to recommend 9.45 ± 1.22; confidence in continuing participation 9.9 ± 0.39. Conclusion Highly motivated participants were marked by strong knowledge of prostate cancer screening, trust in healthcare providers, supportive social context, and high personal commitment. These findings support personalized, socially supportive, educational strategies to increase uptake of state-of-the-art screening.

Keywords: prostate cancer screening, PSA testing, biparametric MRI, Decisional balance scale, Early detection, Prostapilot study

Received: 13 Jun 2025; Accepted: 03 Nov 2025.

Copyright: © 2025 Svetlak, Standara, Malatincová, Staník, Miklánek, Hejcmanová, Pacal, Hrabec, Ngo, Hejduk, Křístek, Uher, Májek and Poprach. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Michal Standara, michal.standara@mou.cz

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.